NOCT
Basic information
Region (hg38): 4:139015781-139045939
Previous symbols: [ "CCRN4L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOCT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 1 |
Variants in NOCT
This is a list of pathogenic ClinVar variants found in the NOCT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-139016013-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
4-139016061-G-A | not specified | Uncertain significance (Jul 16, 2021) | ||
4-139016156-T-G | not specified | Uncertain significance (Jan 03, 2022) | ||
4-139016166-G-C | not specified | Uncertain significance (Sep 17, 2021) | ||
4-139043197-T-C | not specified | Uncertain significance (Dec 28, 2022) | ||
4-139043230-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
4-139043286-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
4-139043288-T-C | Benign (May 29, 2018) | |||
4-139044674-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
4-139044725-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
4-139044856-T-G | not specified | Uncertain significance (May 21, 2024) | ||
4-139044899-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
4-139044907-C-T | Likely benign (Apr 04, 2018) | |||
4-139044947-G-A | not specified | Uncertain significance (May 09, 2023) | ||
4-139045020-G-T | not specified | Uncertain significance (Feb 27, 2024) | ||
4-139045025-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
4-139045281-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
4-139045297-G-T | not specified | Uncertain significance (Oct 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NOCT | protein_coding | protein_coding | ENST00000280614 | 3 | 29964 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0421 | 0.952 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.896 | 170 | 206 | 0.824 | 0.0000107 | 2766 |
Missense in Polyphen | 41 | 66.731 | 0.6144 | 815 | ||
Synonymous | -1.40 | 100 | 83.7 | 1.19 | 0.00000433 | 911 |
Loss of Function | 2.43 | 5 | 15.3 | 0.328 | 9.89e-7 | 165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000706 | 0.0000703 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Circadian deadenylase which plays an important role in post-transcriptional regulation of metabolic genes under circadian control. Degrades poly(A) tails of specific target mRNAs leading to their degradation and suppression of translation. Exerts a rhythmic post-transcriptional control of genes necessary for metabolic functions including nutrient absorption, glucose/insulin sensitivity, lipid metabolism, adipogenesis, inflammation and osteogenesis. Plays an important role in favoring adipogenesis over osteoblastogenesis and acts as a key regulator of the adipogenesis/osteogenesis balance. Promotes adipogenesis by activating PPARG transcriptional activity in a deadenylase- independent manner by facilitating its nuclear translocation. Regulates circadian expression of NOS2 in the liver and negatively regulates the circadian expression of IGF1 in the bone. Critical for proper development of early embryos (By similarity). {ECO:0000250}.;
- Pathway
- BMAL1-CLOCK,NPAS2 activates circadian gene expression;Circadian Clock;BMAL1:CLOCK,NPAS2 activates circadian gene expression
(Consensus)
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.74
Haploinsufficiency Scores
- pHI
- 0.271
- hipred
- Y
- hipred_score
- 0.518
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Noct
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- deadenylation-dependent decapping of nuclear-transcribed mRNA;regulation of transcription, DNA-templated;transcription by RNA polymerase II;mRNA processing;circadian rhythm;response to extracellular stimulus;negative regulation of gene expression;response to lipopolysaccharide;circadian regulation of gene expression;cytoplasmic mRNA processing body assembly;regulation of circadian rhythm;positive regulation of fat cell differentiation;negative regulation of osteoblast differentiation;regulation of embryonic development;mRNA stabilization;RNA phosphodiester bond hydrolysis, exonucleolytic
- Cellular component
- P-body;nucleus;nucleoplasm;cytoplasm;perinuclear region of cytoplasm
- Molecular function
- DNA-binding transcription factor activity;mRNA binding;poly(A)-specific ribonuclease activity;metal ion binding